Clinical Trial Update: A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy

View source ↗

Summary

Clinical trial update describing a study that evaluates disease characteristics in adult male participants with Hemophilia B receiving prophylaxis with standard…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Factor IX protein (FIX) replacement therapy (Factor IX)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Hemophilia B | Status: ACTIVE_NOT_RECRUITING